Amitriptyline is effective in chronic but not in episodic tension-type headache: pathogenetic implications

Headache
R CerboT Catarci

Abstract

The tricyclic antidepressant, amitriptyline, is an effective drug for the treatment of chronic tension-type headache and for other chronic pain syndromes, but it is also effective in the prophylaxis of an episodic type of headache such as migraine. However, its efficacy in episodic tension-type headache has not yet been clarified. We compared the efficacy of amitriptyline (25 mg/day) in 82 nondepressed patients with either chronic or episodic tension-type headache in an open-label study. Amitriptyline significantly reduced (P < 0.05) frequency and duration of headache as well as analgesic consumption in chronic, but not in episodic, tension-type headache. Further placebo-controlled trials, possibly with higher doses of amitriptyline, might confirm if the different pattern of response to amitriptyline can be explained in terms of different involvement of central nociception and of peripheral myofascial factors in the chronic and in the episodic forms of tension-type headache.

Citations

Sep 5, 2002·Current Pain and Headache Reports·Mark J Stillman
Jan 5, 2008·Current Pain and Headache Reports·Marc E Lenaerts
Nov 1, 2008·Current Pain and Headache Reports·Marcelo E BigalRichard Hargreaves
Feb 17, 2001·Current Treatment Options in Neurology·Rigmor Jensen
Aug 11, 2000·European Journal of Pharmacology·J H SongC S Lee
Apr 12, 2000·Headache·C Redillas, S Solomon
Dec 21, 2004·Cephalalgia : an International Journal of Headache·W B Young, T D Rozen
Mar 10, 2007·Cephalalgia : an International Journal of Headache·N P ZissisK Karageorgiou
May 11, 2010·Drugs & Aging·Matthew S Robbins, Richard B Lipton
Oct 16, 2014·Drugs & Aging·Stephanie Wrobel GoldbergBrian M Grosberg
Jun 28, 2000·Current Opinion in Neurology·R Jensen, J Olesen
Jun 28, 2000·Current Opinion in Neurology·S D Silberstein, R B Lipton
May 26, 2009·Expert Opinion on Pharmacotherapy·Marc E Lenaerts
Apr 20, 2010·Clinical Neurology and Neurosurgery·Elza MagalhãesAilton Melo
Oct 13, 2000·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·S Margulies
Oct 13, 2006·Bioorganic & Medicinal Chemistry·Debjani P HudgensMilton L Brown
Jul 12, 2005·Clinics in Sports Medicine·Elliot L Dimberg, Ted M Burns
Jun 3, 2004·Primary Care·John Claude Krusz
Dec 4, 2003·Expert Opinion on Pharmacotherapy·Chonghao Zhao, Mark J Stillman
Apr 18, 2015·Disease-a-month : DM·Irene A Semenov
Oct 25, 2002·The Journal of Pharmacy and Pharmacology·Florentina PenaMaria-Luisa Flonta
Mar 1, 2003·Expert Review of Neurotherapeutics·Lars Bendtsen
Nov 2, 2001·Hospital Medicine·H C Romer
Sep 27, 2018·Journal of the American Geriatrics Society·Thomas BerkBrinder Vij
Sep 29, 2011·CNS Neuroscience & Therapeutics·Todd A SmithermanDonald B Penzien
Sep 4, 2018·Singapore Medical Journal·Vivien Min Er LeeVictor Weng Keong Loh
May 19, 2021·Neurology India·Sanjeev Kumar BhoiDebashish Chowdhury

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.